Stevanato Group S.p.A.
STVNNYSEHealthcareMedical Instruments & Supplies

About Stevanato Group S.p.A.

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass forming machines; and after-sales services, such as spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug product, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Stock Details

ExchangeNYSE (NYSE)
CurrencyEUR - EUR
TypeStock

Contact Information

Phone39 04 99 31 811
Address
Via Molinella 17 Piombino Dese, PD 35017 Italy

Corporate Identifiers

CIK0001849853
CUSIPT9224W109
ISINIT0005452658
SIC3841

Leadership Team & Key Executives

Franco Stevanato
Chief Executive Officer and Executive Chairman
Marco Dal Lago
Chief Financial Officer
Lisa Miles
Chief Communications and Investor Relations Officer
Carla Costa
Chief Human Resources Officer
Mauro Stocchi
Chief Business Strategy Officer
Michele Monico
President of DDS and IVD Business Unit
Raffaele Pace
President of Engineering Business Unit